ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Medical Oncology

Top Medical Oncology Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALEDA TOMA M.D.

Medical Oncology

2,475

$632K

312
274 are 65+

13%
patients receiving schedule two controlled substances

8%
patients receiving schedule three controlled substances

4%
prescriptions for patients 65+ for potentially dangerous drugs

16%
prescriptions for brand name drugs

$255
Average prescription price

NASSER JANBAY M.D.

Medical Oncology

1,414

$566K

228
166 are 65+

17%
patients receiving schedule two controlled substances

12%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

14%
prescriptions for brand name drugs

$400
Average prescription price

RAVIKUMAR VASIREDDY MD

Medical Oncology

1,206

$775K

199
163 are 65+

27%
patients receiving schedule two controlled substances

8%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

17%
prescriptions for brand name drugs

$642
Average prescription price

ROMEO MANDANAS M.D.

Medical Oncology

1,157

$760K

122
89 are 65+

18%
patients receiving schedule two controlled substances

19%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

28%
prescriptions for brand name drugs

$657
Average prescription price

SUMBAL NABI MD

Medical Oncology

711

$287K

110
90 are 65+

18%
patients receiving schedule two controlled substances

18%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

13%
prescriptions for brand name drugs

$403
Average prescription price

COTY HO M.D.

Medical Oncology

672

$394K

104
85 are 65+

14%
patients receiving schedule two controlled substances

21%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

14%
prescriptions for brand name drugs

$587
Average prescription price

JENNIFER O'STASIK M.D.

Medical Oncology

653

$283K

131
105 are 65+

12%
patients receiving schedule two controlled substances

16%
patients receiving schedule three controlled substances

5%
prescriptions for patients 65+ for potentially dangerous drugs

14%
prescriptions for brand name drugs

$433
Average prescription price

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank